{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:41:42Z","timestamp":1793115702527,"version":"4.5.0"},"reference-count":51,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2019,11,1]]},"DOI":"10.1001\/jamapediatrics.2019.3203","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T04:01:33Z","timestamp":1569902493000},"page":"1084","source":"Crossref","is-referenced-by-count":46,"title":["Prevalence of Immunodeficiency in Children With Invasive Pneumococcal Disease in the Pneumococcal Vaccine Era"],"prefix":"10.1001","volume":"173","author":[{"given":"Coen","family":"Butters","sequence":"first","affiliation":[{"name":"Infectious Diseases Unit, The Royal Children\u2019s Hospital, Melbourne, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linny Kimly","family":"Phuong","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, The Royal Children\u2019s Hospital, Melbourne, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Cole","sequence":"additional","affiliation":[{"name":"Department of Allergy and Immunology, The Royal Children\u2019s Hospital, Melbourne, Parkville, Australia"},{"name":"Department of Paediatrics, The University of Melbourne, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Gwee","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, The Royal Children\u2019s Hospital, Melbourne, Parkville, Australia"},{"name":"Department of Paediatrics, The University of Melbourne, Parkville, Australia"},{"name":"Infectious Diseases & Microbiology Research Group, Murdoch Children\u2019s Research Institute, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"prv190001r1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12325-013-0007-6","article-title":"The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review.","volume":"30","author":"Myint","year":"2013","journal-title":"Adv Ther"},{"issue":"3","key":"prv190001r2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"prv190001r3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/cid\/ciy842","article-title":"Invasive pneumococcal disease in UK children under 1 year of age in the post-PCV13 era: what are the risks now?","volume":"69","author":"Kent","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"prv190001r4","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/S2214-109X(16)30306-0","article-title":"Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis.","volume":"5","author":"Shiri","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"9693","key":"prv190001r5","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"prv190001r6","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/00130832-200312000-00006","article-title":"Primary immunodeficiencies associated with pneumococcal disease.","volume":"3","author":"Picard","year":"2003","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"prv190001r7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/clinids\/7.2.133","article-title":"Invasive pneumococcal infections: incidence, predisposing factors, and prognosis.","volume":"7","author":"Burman","year":"1985","journal-title":"Rev Infect Dis"},{"issue":"1","key":"prv190001r8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jinf.2012.02.017","article-title":"The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England.","volume":"65","author":"van Hoek","year":"2012","journal-title":"J Infect"},{"issue":"9","key":"prv190001r9","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/cid\/civ059","article-title":"Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013.","volume":"60","author":"von Mollendorf","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"prv190001r10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity.","volume":"38","author":"Picard","year":"2018","journal-title":"J Clin Immunol"},{"issue":"1","key":"prv190001r11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/ijcp.12234","article-title":"The burden of invasive pneumococcal disease in children with underlying risk factors in North America and Europe.","volume":"68","author":"Rose","year":"2014","journal-title":"Int J Clin Pract"},{"issue":"5","key":"prv190001r12","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1111\/1462-2920.13686","article-title":"Air pollution alters Staphylococcus aureus and Streptococcus pneumoniae biofilms, antibiotic tolerance and colonisation.","volume":"19","author":"Hussey","year":"2017","journal-title":"Environ Microbiol"},{"issue":"3","key":"prv190001r13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/INF.0b013e3181fab1cf","article-title":"Underlying conditions in children with invasive pneumococcal disease in the conjugate vaccine era.","volume":"30","author":"Hsu","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"prv190001r14","first-page":"B5126","article-title":"Recurrent invasive pneumococcal disease in children\u2014host factors and vaccination response.","volume":"62","author":"Ingels","year":"2015","journal-title":"Dan Med J"},{"issue":"6","key":"prv190001r15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/MD.0b013e3181fd8ec3","article-title":"Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.","volume":"89","author":"Picard","year":"2010","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"prv190001r17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"issue":"5","key":"prv190001r19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/INF.0000000000001470","article-title":"Risk factors in children older than 5 years with pneumococcal meningitis: data from a national network.","volume":"36","author":"H\u00e9naff","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"prv190001r20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/INF.0000000000000701","article-title":"Immunodeficiency among children with recurrent invasive pneumococcal disease.","volume":"34","author":"Ingels","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"prv190001r21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1753425918762038","article-title":"How many single-nucleotide polymorphisms (SNPs) must be tested in order to prove susceptibility to bacterial meningitis in children? analysis of 11 SNPs in seven genes involved in the immune response and their effect on the susceptibility to bacterial meningitis in children.","volume":"24","author":"Gowin","year":"2018","journal-title":"Innate Immun"},{"issue":"5","key":"prv190001r22","doi-asserted-by":"publisher","first-page":"e0178377","DOI":"10.1371\/journal.pone.0178377","article-title":"Mannose-binding lectin-deficient genotypes as a risk factor of pneumococcal meningitis in infants.","volume":"12","author":"Bautista-Rodriguez","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"prv190001r23","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1097\/INF.0000000000000779","article-title":"Association of polymorphisms in IRAK1, IRAK4 and MyD88, and severe invasive pneumococcal disease.","volume":"34","author":"Carrasco-Colom","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"prv190001r24","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1093\/cid\/ciu276","article-title":"Mannose-binding lectin gene, MBL2, polymorphisms are not associated with susceptibility to invasive pneumococcal disease in children.","volume":"59","author":"Lundbo","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"prv190001r25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1542\/peds.2014-2426","article-title":"Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease.","volume":"135","author":"Yildirim","year":"2015","journal-title":"Pediatrics"},{"issue":"2","key":"prv190001r26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/cid\/ciu274","article-title":"Invasive pneumococcal disease in children can reveal a primary immunodeficiency.","volume":"59","author":"Gaschignard","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"10","key":"prv190001r27","doi-asserted-by":"publisher","first-page":"O745","DOI":"10.1111\/1469-0691.12615","article-title":"High prevalence of genetically-determined mannose binding lectin deficiency in young children with invasive pneumococcal disease.","volume":"20","author":"Mu\u00f1oz-Almagro","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"prv190001r28","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1183\/09031936.00171409","article-title":"Serotype-specific pneumococcal disease may be influenced by mannose-binding lectin deficiency.","volume":"36","author":"Vall\u00e8s","year":"2010","journal-title":"Eur Respir J"},{"issue":"3","key":"prv190001r29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.clim.2006.10.012","article-title":"Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infection.","volume":"122","author":"Hirschfeld","year":"2007","journal-title":"Clin Immunol"},{"issue":"4","key":"prv190001r30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/00006454-200204000-00004","article-title":"Invasive pneumococcal infections in children with asplenia.","volume":"21","author":"Schutze","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"prv190001r31","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/ije\/27.6.1101","article-title":"Paediatric, invasive pneumococcal disease in Switzerland, 1985-1994.","volume":"27","author":"Venetz","year":"1998","journal-title":"Int J Epidemiol"},{"issue":"3","key":"prv190001r32","doi-asserted-by":"publisher","first-page":"e0118848","DOI":"10.1371\/journal.pone.0118848","article-title":"Recurrent invasive pneumococcal disease in children: underlying clinical conditions, and immunological and microbiological characteristics.","volume":"10","author":"Alsina","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"prv190001r33","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/INF.0b013e31805ce277","article-title":"Recurrent systemic pneumococcal disease in children.","volume":"26","author":"Mason","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"prv190001r34","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1469-0691.2005.01221.x","article-title":"Nationwide study of recurrent invasive pneumococcal infections in a population with a low prevalence of human immunodeficiency virus infection.","volume":"11","author":"Einarsd\u00f3ttir","year":"2005","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"prv190001r35","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0022-3476(97)70356-1","article-title":"Repeated invasive pneumococcal infections in young children without apparent underlying immunodeficiency.","volume":"130","author":"Orlicek","year":"1997","journal-title":"J Pediatr"},{"issue":"7","key":"prv190001r36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/pai.2011.22.issue-7","article-title":"Clinical characteristics of pediatric patients evaluated for primary immunodeficiency.","volume":"22","author":"MacGinnitie","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"key":"prv190001r37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1749-6632.2011.06206.x","article-title":"Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century.","volume":"1238","author":"Arkwright","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"1-3","key":"prv190001r38","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12026-008-8092-3","article-title":"From genotype to phenotype: further studies measuring the impact of a physician education and public awareness campaign on early diagnosis and management of primary immunodeficiencies.","volume":"44","author":"Modell","year":"2009","journal-title":"Immunol Res"},{"issue":"7","key":"prv190001r39","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"7","key":"prv190001r40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1542\/pir.35-7-299","article-title":"Pneumococcal infections.","volume":"35","author":"Maraqa","year":"2014","journal-title":"Pediatr Rev"},{"key":"prv190001r41","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3389\/fimmu.2014.00627","article-title":"Primary immune deficiencies\u2014principles of care.","volume":"5","author":"Chapel","year":"2014","journal-title":"Front Immunol"},{"issue":"4","key":"prv190001r42","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s10875-014-0003-x","article-title":"ICON: the early diagnosis of congenital immunodeficiencies.","volume":"34","author":"Routes","year":"2014","journal-title":"J Clin Immunol"},{"issue":"3","key":"prv190001r43","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10875-011-9511-0","article-title":"Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study.","volume":"31","author":"Quinti","year":"2011","journal-title":"J Clin Immunol"},{"issue":"12","key":"prv190001r44","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s10096-010-1049-1","article-title":"Assessment of splenic function.","volume":"29","author":"de Porto","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"prv190001r45","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1182\/blood.V85.8.2238.bloodjournal8582238","article-title":"Functional asplenia in hemoglobin SC disease.","volume":"85","author":"Lane","year":"1995","journal-title":"Blood"},{"issue":"5","key":"prv190001r46","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/ajh.v87.5","article-title":"Hyposplenism: comparison of different methods for determining splenic function.","volume":"87","author":"Lammers","year":"2012","journal-title":"Am J Hematol"},{"issue":"11","key":"prv190001r47","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1086\/379324","article-title":"Impact of mannose-binding lectin on susceptibility to infectious diseases.","volume":"37","author":"Eisen","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"1-2","key":"prv190001r48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0022-1759(00)00198-8","article-title":"Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers.","volume":"241","author":"Steffensen","year":"2000","journal-title":"J Immunol Methods"},{"issue":"7","key":"prv190001r49","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/gepi.v33:7","article-title":"STrengthening the REporting of Genetic Association Studies (STREGA)\u2014an extension of the STROBE statement.","volume":"33","author":"Little","year":"2009","journal-title":"Genet Epidemiol"},{"issue":"51","key":"prv190001r50","doi-asserted-by":"crossref","first-page":"E7128","DOI":"10.1073\/pnas.1521651112","article-title":"Severe infectious diseases of childhood as monogenic inborn errors of immunity.","volume":"112","author":"Casanova","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"prv190001r51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1473-3099(08)70261-5","article-title":"Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis.","volume":"9","author":"Brouwer","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"prv190001r16","unstructured":"MoinhoR, BrettA, FerreiraG, LemosS. Pneumococcal vaccine failure: can it be a primary immunodeficiency? [published online June 12, 2014] BMJ Case Rep. doi:10.1136\/bcr-2014-20471424925540"},{"key":"prv190001r18","unstructured":"Oxford Centre for Evidence-Based Medicine\u2014levels of evidence. https:\/\/www.cebm.net\/2009\/06\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009\/. Published March 2009. Accessed January 26, 2019."}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2751746\/jamapediatrics_butters_2019_rv_190001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T16:33:47Z","timestamp":1664555627000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2751746"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2019.3203","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,1]]}}}